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Abstract
Introduction Integrative analysis of multiple data sets can provide complementary information about the studied biological 
system. However, data fusion of multiple biological data sets can be complicated as data sets might contain different sources 
of variation due to underlying experimental factors. Therefore, taking the experimental design of data sets into account could 
be of importance in data fusion concept.
Objectives In the present work, we aim to incorporate the experimental design information in the integrative analysis of 
multiple designed data sets.
Methods Here we describe penalized exponential ANOVA simultaneous component analysis (PE-ASCA), a new method for 
integrative analysis of data sets from multiple compartments or analytical platforms with the same underlying experimental 
design.
Results Using two simulated cases, the result of simultaneous component analysis (SCA), penalized exponential simultane-
ous component analysis (P-ESCA) and ANOVA-simultaneous component analysis (ASCA) are compared with the proposed 
method. Furthermore, real metabolomics data obtained from NMR analysis of two different brains tissues (hypothalamus 
and midbrain) from the same piglets with an underlying experimental design is investigated by PE-ASCA.
Conclusions This method provides an improved understanding of the common and distinct variation in response to different 
experimental factors.
Keywords ANOVA-simultaneous component analysis (ASCA) · Multiset data analysis · Data integration · NMR 
metabolomics · Concave penalty
1 Introduction
With an increased availability of data from multiple sources, 
data fusion is one of the main challenges in omics sciences, 
such as metabolomics (Crockford et al. 2006; Smilde et al. 
2005b). Different pieces of information can be captured 
from the same set of objects with the same or with differ-
ent features. Collected data from multiple compartments 
(i.e. biological fluids and tissues) (Noguchi et al. 2006) or 
analytical platforms (Crockford et al. 2006) with the same 
set of objects are examples of this situation. Integrative 
analysis of these multiple data sets with a shared mode (i.e. 
object or variable direction) can be useful for improving the 
understanding of the studied biological system. A number 
of different methods are proposed to capture the same latent 
phenomena in different data sets (i.e. common variation) as 
well as the phenomena which can only be found in one data 
matrix (i.e. distinct variation) (Smilde et al. 2017; Van Deun 
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et al. 2012, 2013). The common variation can be used to 
explain association between different data sets such as same 
pattern of variability, while the distinct variation can provide 
a better understanding of specific source of variability in 
each data set. Methods such as generalized SVD (GSVD) 
(Alter et al. 2003), joint and individual variation explained 
(JIVE) (Lock et al. 2013), distinct and common simultane-
ous component analysis (DISCO-SCA) (Schouteden et al. 
2013), two block orthogonal partial least squares (O2-PLS) 
(Trygg and Wold 2003) attempt to capture both common 
and distinct sources of variation across different data sets. 
However, these methods use different approaches in select-
ing the number of common and distinct components, and in 
many cases do not agree (Måge et al. 2019; van der Kloet 
et al. 2016) . Recently, methods such as structural learning 
and integrative decomposition (SLIDE) (Gaynanova and Li 
2017) and penalized exponential simultaneous component 
analysis (P-ESCA) (Song et al. 2019) with the possibility of 
modeling partially shared variation and component selection 
(i.e. identification of the number of components for com-
mon and distinct variation) are developed. In the P-ESCA 
model, a group sparsity constraint has been used to find the 
global and local common and distinct components using a 
concave penalty.
Metabolomics data sets are highly complex as they mostly 
contain different underlying designed experimental factors, 
such as treatment, time, diets, doses of the drug, etc. (Antti 
et al. 2004). Even though data fusion is crucial for under-
standing the relationship between different data sets, current 
data fusion methods (Alter et al. 2003; Gaynanova and Li 
2017; Lock et al. 2013; Schouteden et al. 2013; Song et al. 
2019; Trygg and Wold 2003) do not take the experimental 
complexity of the data sets into account. This means that 
different sources of variation explaining the contribution of 
the experimental design are not described in the data fusion 
models, which could hamper an easy interpretation of the 
common and distinct sources of variation. ANOVA simul-
taneous component analysis (ASCA) (Jansen et al. 2005b; 
Smilde et al. 2005a) is widely used for the analysis of the 
complicated multivariate data with many measured variables 
from a designed metabolomics study. ASCA can decompose 
the data to low-rank submatrices that can be assigned to dif-
ferent experimental factors and their interactions.
In this paper, we aim to merge ASCA with fusion meth-
ods to provide the common and distinct sources of variation 
related to each factor, interaction or their combination as 
well as the individual differences of the objects that cannot 
be explained by designed factors. This can be crucial for 
understanding the underlying information in multiple bio-
logical data sets and allows for an easy interpretation of the 
common and distinct latent components for separated vari-
ation induced by different designed factors. The proposed 
penalized exponential ANOVA simultaneous component 
analysis (PE-ASCA) model presented here can deal with 
the complexity of the designed biological data in data 
fusion concept. Therefore, two simulated data sets and a 
real nuclear magnetic resonance (NMR) metabolomics data 
set with experimental design are analyzed by the PE-ASCA 
model. Significance of the experimental factors will be quan-
tified by calculating the p values using a permutation test 
(Vis et al. 2007; Zwanenburg et al. 2011). The metabolomics 
data, analyzed in this paper, is part of an intervention study 
(Alinaghi et al. 2019; Møller et al. 2011) where data from 
multiple compartments are available for the same piglets to 
investigate bloodstream infection. However, the experimen-
tal design of the newborn piglets cause the need for a fusion 
model which can deal with the complexity of the designed 
biological data. Neonatal sepsis, the clinical manifestation 
of a severe bloodstream infection in early life, may injure the 
developing brain and cause neurodevelopmental impairment 
(Stoll et al. 2004). Efforts to reduce systemic inflammation 
by supplementation of the bovine colostrum (COL) might 
reduce the risk of brain injury and improve the long-term 
outcomes. Colostrum, the first milk after birth in mammals 
(Møller et al. 2011), contains a multitude of proteins and 
peptides with anti-inflammatory and anti-microbial prop-
erties which seem to protect the immature newborns from 
harmful inflammatory reactions and brain injury. Therefore, 
high-resolution magic-angle spinning (HR-MAS) NMR 
spectroscopy was applied to study how neonatal bloodstream 
infection would diet-dependently change the metabolome of 
different brain tissues.
2  Theory
In this section we will shortly introduce the SCA, ASCA 
and P-ESCA models and discuss their properties. SCA is 
a general extension of PCA when multiple data sets of the 
same samples are available, ASCA is a method for decom-
posing multivariate data into effect matrices, according to an 
experimental design, after which the effect matrices can be 
explored separately. The P-ESCA model is able to find com-
mon and distinctive variation in multiple sets of data. Then, 
using the same notation we will introduce the PE-ASCA 
model and discuss its superior properties over the previous 
models when there is an experimental design underlying two 
or more data sets measured on the same samples. Properties 
of these models are summarized in Table 1.
2.1  SCA model
Simultaneous component analysis (SCA) (Jansen et  al. 
2005a; Ten Berge et al. 1992) can simultaneously analyzed 
multiple data sets with a shared object mode (measuring 
different features for the same set of objects). Suppose 퐗n 
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contains the same number of rows I and possibly different 
number of columns Jn, then SCA can decompose each data 
set according to Eq. (1).
where 퐗n ∈ RI×Jn , where n = 1,… ,N  corresponds to the 
various multivariate data sets, whose rows contain the 
measurement of objects i = 1,… , I and columns contain 
the measurement of variables jn = 1,… , Jn. 퐓 ∈ RI×R is 
the common score matrix with r = 1,… ,R number of sig-
nificant common components and 퐏n ∈ RJn×R contains the 
relevant loadings for each data 퐗n. 퐄n ∈ RI×Jn is the residual 
matrix.
2.2  ASCA model
Analysis of variance (ANOVA) (Searle 1971) can be used 
to determine the effect of different experimental factors on 
a single measured response. Based on the basic idea of the 
ANOVA, ASCA can decompose a multivariate data set to 
orthogonal and independent sub-matrices explaining the 
variation induced by experimental factors. For the situation 
with more than one data matrix with a shared object mode, 
the ASCA decomposition can be applied for each data set 
퐗n separately. The ASCA decomposition for multivariate 
data with a two-way experimental design of factors α and β 
containing different levels can be seen in Eq. (2).
where 1 is a column vector of ones of size I, 퐦n is a column 
vector of size Jn with overall means of responses per varia-
ble; matrices 퐗n훼 , 퐗n훽 and 퐗n훼훽 ∈ RI×Jn contain the estimated 
values of the experimental factor α, β and the interaction αβ, 
while each row of the matrices 퐗n훼 and 퐗n훽 is related to one 
level of the factors α and β respectively. 퐗n,ind ∈ RI×Jn is 
a matrix containing all the individual differences between 
the objects after subtracting all effect matrices. As all rows 
(1)퐗n = 퐓퐏Tn + 퐄n
(2)퐗n = 1퐦Tn + 퐗n훼 + 퐗n훽 + 퐗n훼훽 + 퐗n,ind
within the same level of a factor have the same values, the 
ASCA decomposed-matrices are low-rank matrices. SCA 
is used to diminish the number of variables Jn to a lower 
number of latent components in matrices 퐗n훼 , 퐗n훽 and 퐗n훼훽 
(Eq. (3)).
where 퐓nl ∈ RI×Rl is the SCA score matrix of ASCA effect 
for factor l with Rl number of significant components and 
퐏nl ∈ R
Jn×Rl contains the relevant loadings. To identify the 
ASCA model, each loading matrix has orthonormal col-
umns, hence, 퐏T
nl
퐏nl = 퐈, l ∈ {훼 , 훽, 훼훽, ind}. Enl ∈ RI×Jn 
contains the residual part of 퐗nl that is not described by the 
SCA model. To prevent the overestimation of the experimen-
tal effects, a permutation test can be performed on the effect 
matrices. The null hypothesis  H0 then represents there is no 
experimental effect larger than estimated effects from per-
muted data between the level averages in the score matrices 
Tl (Zwanenburg et al. 2011).
For the situations that factor β is not independently of 
interest, its combination with the interaction (퐗n훽 + 퐗n훼훽 ) 
can be evaluated, especially when the time factor is desired 
(Jansen et al. 2005b). In this paper, the combination β + αβ 
is considered for investigation. Combination of the time 
and treatment effect is interpreted as the trend of changes 
in treatment levels over time. If we assume that factor α has 
K levels k = 1,… ,K and factor β has H levels h = 1,… ,H, 
each individual can be represented as a combination of spe-
cific level of factor α and β; i.e. ikh = 1,… , Ikh (Fig. 1). The 
rank of the matrix describing factor α is (K − 1) and the rank 
for the factor matrix related to β is (H − 1). The rank of the 
combination of factor β and interaction is (K − 1)H.
2.3  P‑ESCA model
According to the P-ESCA model (Song et al. 2019), com-
mon and distinct components can be disentangled from mul-
tiple data sets by applying structured sparsity on the SCA 
loading matrix. Fused data matrices can be decomposed to 
low dimensional matrices of common and distinct variation 
according to Eq. (4).
where subscript c stands for the common variation and sub-
script d stands for the distinct variation. For the simplicity, 
local common variation is not considered here and 퐗nc con-
tains the global common variation. 퐄n contains the nonsys-
tematic variation. For the integrative analysis of multiple 
data sets with shared objects, the P-ESCA disentangles a 
score matrix with the size of I × R where r = 1,… ,R repre-
sents the number of significant components (for common and 
distinct combined) and a loading of size (J1 +…+ Jn) × R 
(3)퐗nl = 퐓nl퐏Tnl + 퐄nll ∈ {훼 , 훽, 훼훽, ind}
(4)퐗n = 퐗nc + 퐗nd + 퐄n = 퐓c퐏Tnc + 퐓nd퐏Tnd + 퐄n,
Table 1  Properties of the SCA, ASCA, P-ESCA and PE-ASCA meth-
ods
Methods Experi-
mentally 
designed 
data
Decomposi-
tion into 
factor effect 
matrices
Decomposi-
tion into 
Common and 
distinctive 
variation
Decomposi-
tion into factor 
effect matrices 
within com-
mon and 
distinctive 
variation
NO YES
SCA X X
ASCA X X
P-ESCA X X X
PE-ASCA X X X X
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with a sparsity pattern. Assuming the integrative analysis of 
two data sets 
[
퐗1 퐗2
]
= 퐓퐏T where 퐓T퐓 = 퐈, then the struc-
ture of the loading 
{
퐏n
}2
n=1
∈ RJn×R is given by in Eq. (5).
where 퐏1,1 and 퐏2,1 represent loadings of the common varia-
tion for 퐗1 and 퐗2, respectively. 퐏1,2 and 퐏2,3 represent load-
ings of the distinct variation of 퐗1 and 퐗2, respectively. By 
incorporating Eq. (5) in the P-ESCA model presented in 
Eq. (4), the following decomposition can be obtained for the 
integrative analysis of two data sets (Eq. (6)).
In cases with the integrative analysis of more than two 
data sets, there might be local common components, which 
can also be disentangled with the P-ESCA model. However, 
this is not of interest in this example since we only have two 
blocks of data.
2.4  Data fusion of multiple designed experimental 
data sets
For incorporating the experimental design in the data fusion, 
two approaches are feasible: (i) first disentangle the common 
and distinct latent components of the data sets by P-ESCA 
and then, decompose common and distinct variation into the 
matrices explaining different experimental design factors by 
(5)퐏 =
(
퐏1
퐏2
)
=
(
퐏1,1 퐏1,2 0
퐏2,1 0 퐏2,3
)
(6)
퐗1 = 퐓c퐏1,1 + 퐓1d퐏1,2 + 퐄1
퐗2 = 퐓c퐏2,1 + 퐓2d퐏2,3 + 퐄2
ASCA, or (ii) first decompose each data set into the matrices 
explaining different experimental design factors by ASCA 
and then, disentangle the common and distinct latent com-
ponents of each factor matrices by P-ESCA. In the noiseless 
case both approaches lead to the same solution and further 
discussion on the comparison of these two approaches can 
be found in the supplementary material (Eqs. (S1)–(S5) and 
Fig. S1). P-ESCA estimates a noise level from the data to 
find the structured loadings. As ASCA already removes the 
individual variation from the data, P-ESCA has more dif-
ficulties finding the correct common and distinct structure 
after ASCA decomposition. Therefore, the first approach has 
been considered for further analysis in this paper.
The ASCA model can be incorporated on the P-ESCA 
decomposition to disentangle the common and distinct latent 
components for separated variation induced by different 
design factors (Eq. (7)).
Therefore, decomposition of multiple data sets is accord-
ing to Eq. (8), which represents the PE-ASCA model.
(7)
퐗
n
=1퐦T
n
+ 퐗
nc훼 + 퐗nc(훽+훼훽) + 퐗nd훼
+ 퐗
nd(훽+훼훽) + 퐗nc,ind + 퐗nd,ind + 퐄n
(8)
퐗
n
=1퐦T
n
+ 퐓
c훼퐏
T
nc훼
+ 퐓
c(훽+훼훽)퐏
T
nc(훽+훼훽)
+ 퐓
c,ind퐏
T
nc,ind
+ 퐓
nd훼퐏
T
nd훼
+ 퐓
nd(훽+훼훽)퐏
T
nd(훽+훼훽)
+ 퐓
nd,ind퐏
T
nd,ind
+ 퐄
n
Fig. 1  Structure of the data sets for integrative analysis. The left 
matrix represents the experimental design matrix with the first col-
umn containing the levels of k = 1, …, K (K = 2) of factor α and sec-
ond column containing the levels of h = 1, …, H (H = 2) of factor β. 
Multiple data sets, 퐗1 and 퐗2, contain the same number of rows I and 
possibly a different number of columns J1 and J2, respectively. Each 
individual can be represented as a specific level of factor α and β 
Common and distinct variation in data fusion of designed experimental data 
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where 퐓c훼 ∈ RI×Rcα is the matrix containing the common 
components explaining the contribution of factor α on the 
basis of 퐏nc훼 ∈ RJn×Rc훼 . 퐓c(훽+훼훽) ∈ RI×Rc(훽+훼훽) is the matrix 
containing common components explaining the combined 
contribution of factor β and interaction αβ on the basis of 
퐏nc(훽+훼훽) ∈ R
Jn×Rnc(훽+훼훽) . 퐓c,ind ∈ RI×Rc,ind is the matrix contain-
ing the common components explaining the contribution 
of individual differences on the basis of 퐏nc,ind ∈ RJn×Rc,ind . 
퐓nd훼 ∈ R
I×Rnd훼 is the matrix containing distinct components 
explaining the contribution of the factor α on the basis of 
퐏nd훼 ∈ R
Jn×Rnd훼 . 퐓nd(훽+훼훽) ∈ RI×Rnd(훽+훼훽) is the matrix contain-
ing distinct components explaining the contribution of factor 
β and interaction αβ on the basis of 퐏nd(훽+훼훽) ∈ RJn×Rnd(훽+훼훽) . 
퐓nd,ind ∈ R
I×Rnd,ind is the matrix containing distinct compo-
nents explaining the contribution of the individual differ-
ences on the basis of 퐏nd,ind ∈ RJn×Rnd,ind .
The loadings of the model for integrative analysis of two 
data sets (n=2) is according to Eq. (9).
where the first, second and third columns represent the com-
mon variation contributing to α, β + αβ effects, and indi-
vidual differences, respectively. The fourth and fifth columns 
represent the distinct sources of variation contributing to 
factor α in first and second data sets, respectively. The sixth 
and seventh columns represent distinct sources of variation 
contributing to β + αβ effect in first and second data sets, 
respectively. The eighth and ninth columns represent the 
distinct sources of variation contributing to the individual 
variation in first and second data sets, respectively.
In the data sets with missing values, the problem can 
be handled by a missing value based cross validation for 
model selection. More explanation on the cross validation 
procedure can be found elsewhere (Song et al. 2019). In case 
of an unbalanced design, where the number of subject per 
group is not the same, an ad hoc resampling approach can 
be used, as was done in this paper, or one could use general-
ized linear models as was suggested by Thiel et al. (Thiel 
et al. 2017). Properties of the SCA, ASCA, P-ESCA and 
PE-ASCA methods can be found in Table 1.
3  Results
3.1  Simulated data
In this section, we investigate the performance of the PE-
ASCA for identification of the common and distinct compo-
nents contributed to each designed factor. Accordingly, the 
(9)
(
퐏1
퐏2
)
=
(
퐏1,1훼 퐏1,2(훽+훼훽) 퐏1,3,ind
퐏2,1훼 퐏2,2(훽+훼훽) 퐏2,3,ind
퐏1,4훼 0 퐏1,6(훽+훼훽)
0 퐏2,5훼 0
0 퐏1,8,ind 0
퐏2,7(훽+훼훽) 0 퐏2,9,ind
)
simulated data sets will be studied to compare the results 
of the proposed method with SCA and P-ESCA (case A), 
as well as ASCA (case B). In each case, two data sets are 
simulated for the integrative analysis (i.e. n = 2). The design 
matrix for simulated data sets is as follows (Eq. (10)).
design matrix =
⎡⎢⎢⎢⎢⎢⎢⎢⎢⎢⎢⎢⎢⎢⎢⎣
1 1
1 2
1 3
⋮ ⋮
2 1
2 2
2 3
⋮ ⋮
3 1
3 2
3 3
⋮ ⋮
⎤⎥⎥⎥⎥⎥⎥⎥⎥⎥⎥⎥⎥⎥⎥⎦
(10)
where the first column represents different levels of factor 
α and the second column represents the levels of factor β. 
To keep the model simple, only one common component is 
considered for each designed factor, i.e. one common factor 
α and one common factor β. This simulation exemplifies 
the situation in which data sets 퐗1 and 퐗2 are obtained by 
analytical measurement of two different biological compart-
ments of the same piglets (six biological replicates measured 
over 100 variables in both cases). The spectral loadings are 
simulated in a way that resemble a simplified metabolomics 
data set (Fig. 2).
Two cases are simulated to illustrate the advantages of 
the PE-ASCA from different aspects. In case A, the results 
of the PE-ASCA are compared with the integrative analysis 
with SCA and P-ESCA which are not considering the experi-
mental design of the data. In case B, the PE-ASCA is com-
pared with the ASCA modeling of different data sets without 
considering the integrative analysis. Matlab (version R2016b, 
MathWorks Inc., United States) was used for data analysis and 
visualization.
3.1.1  Case A
In this case, the simulated data sets are generated according 
to Eq. (11).
(11)퐗1 = 퐭c훼퐩T1c훼 + 퐭c훽퐩T1c훽 + 퐭1d훽퐩T1d훽 + 퐄1
퐗2 = 퐭c훼퐩
T
2c훼
+ 퐭c훽퐩
T
2c훽
+ 퐭2d,ind퐩
T
2d,ind
+ 퐄2
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where 퐭c훼 is the common component contributed to the vari-
ation of factor α (litter effect); 퐭c훽 is the common component 
contributed to the variation of β (treatment effect);퐭1d훽 is 
the distinct component of first data contributed to the varia-
tion of β (treatment effect); 퐭2d,ind is the distinct component 
of second data contributed to the individual variation. The 
simulated score matrices are independent and orthogonal to 
each other. The error matrices 퐄1 and 퐄2 are from a normal 
distribution with an average of zero and a standard deviation 
of 0.01. Signal-to-noise ratios for both 퐗1 and 퐗2 are 35.
In this case, no interaction is considered between litter 
and treatment factors. The litter effect, with three levels (i.e. 
level 1, 2 and 3), is explaining differences in piglets born 
from different sows. The treatment effect has three levels 
where level one relates to infected piglets, level two repre-
sents untreated infected piglets treated with supplementa-
tion, and level three represents the uninfected control piglets 
(CON). The simulated common and distinct components can 
be seen in the left part of Fig. 2. The common litter compo-
nent ( 퐭c훼 ) is simulated with an increasing effect from level 
one to level three. The infected group is separated from the 
other two groups as a common treatment component ( 퐭c훽 ). 
A distinct component explaining the treatment effect is pre-
sent in the first data set ( 퐭1d ), where separation of all three 
treatment groups can be seen in this component. The distinct 
component of the second data set ( 퐭2d,ind ) is explaining the 
individual variation of piglets and is not explaining any con-
tribution to the designed factors. Variable 30 is responsible 
for both common litter and treatment variation, while vari-
able 60 is responsible for distinct treatment variation of first 
data and variable 70 is responsible for individual variation 
in second data (Fig. 2).
To evaluate the performance of the model in capturing 
the correct common and distinct components of designed 
factors, all resolved profiles of the PE-ASCA are visualized 
and compared with the result of SCA and P-ESCA (Fig. 2). 
The first score of the SCA shows the overall litter and com-
mon treatment effects which are corresponding to variable 
30. The second and third scores are explaining the distinct 
variation in both data sets, while the second score is mostly 
contributing to the individual variation in the second data 
and the third score is mostly explaining the distinct treatment 
factor in first data. Generally, SCA could not resolve the sim-
ulated factors correctly. The integrative analysis of two data 
sets by P-ESCA model resulted in one common component 
explaining 54.3% variation of the first data and 54.1% vari-
ation of the second data. This common component contains 
information of both litter and treatment effect. On the other 
hand, the P-ESCA model is able to disentangle the distinct 
effects, while 퐩1d is only explaining variable 60 in first data 
and 퐩2d is contributing to variable 70 in the second data. The 
distinct component 퐭1d, which represents the separation of 
all three treatment groups, explains 16.1% of the variation 
of the first data. The distinct component 퐭2d is explaining 
16.2% of the variation in the second data, which represents 
the individual variation in 퐗2. Even though the results of 
Fig. 2  Simulated data for case A and the scores and loadings obtained by SCA, P-ESCA and PE-ASCA model
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P-ESCA show that the model is capable of separating the 
common and distinct factors, 퐭c is capturing the combination 
of both common litter and treatment effects.
In the PE-ASCA model, the common variation is repre-
sented by two common components describing the experi-
mental effects α and β. The results show the correct separa-
tion of all simulated factors by considering the experimental 
design of data. Therefore, ASCA on common variation of 퐗1 
and 퐗2 resulted in the correct estimation of common litter 
and common treatment effect as separate components ( 퐭c litter 
and 퐭c treatment respectively). A permutation test, performed 
on the effect matrices, showed that the litter and treatment 
effects are both significant with a p value = 0.001 for 1000 
iterations. Performing the ASCA on distinct variation of the 
first data resulted in 퐭d treatment which is contributed to the 
variation of the treatment factor specific to the first data with 
a significant p value = 0.001 for 1000 iterations. ASCA on 
the distinct variation of the second data could not explain 
any significant effect to the experimental factors, however 
an individual pattern of the variation can be revealed in the 
second data. The corresponding loadings separately show 
the correct variables for the common and distinct variation.
3.1.2  Case B
In this case, the simulated data sets are generated according 
to Eq. (12).
(12)
퐗1 = 퐭c훼퐩
T
1c훼
+ 퐭c(훽+훼훽)퐩
T
1c(훽+훼훽)
+ 퐭1d(훽+훼훽)퐩
T
1d(훽+훼훽)
+ 퐄1
퐗2 = 퐭c훼퐩
T
2c훼
+ 퐭c(훽+훼훽)퐩
T
2c(훽+훼훽)
+ 퐄2
퐗2 = 퐭c훼퐩
T
2c훼
+ 퐭c(훽+훼훽)퐩
T
2c(훽+훼훽)
+ 퐄2
where 퐭c훼 is the common component contributed to the vari-
ation of factor α (time effect); 퐭c(훽+훼훽) is the common com-
ponent contributed to the variation of β + αβ (combination 
of treatment and treatment × time effect);퐭1d(훽+훼훽) is the dis-
tinct component of first data set contributed to the variation 
of β + αβ (combination of treatment and treatment × time 
effect). The error matrices 퐄1 and 퐄2 are from a standard 
normal distribution with an average of zero and a standard 
deviation of 0.01. Signal-to-noise ratios for 퐗1 and 퐗2 are 
38 and 33, respectively.
The time effect has four levels (i.e. four time points where 
the level increases with time). The treatment effect has four 
levels with level one related to infected piglets, level two 
represents the infected piglets treated with the first type 
of supplementation (Treated1), level three is the infected 
piglets treated with the second type of supplementation 
(Treated2), and level four is the uninfected control piglets 
(CON). Variable 20 is responsible for the common compo-
nent of time effect, while variable 40 is responsible for the 
common component for the combination of treatment and 
treatment × time effect. The score matrices are simulated to 
be orthogonal to each other in each time point. Therefore, 
in the common score, the Treated1 and Treated2 groups are 
zero over all time points, while the infected and CON groups 
are zero over all time points in the distinct score of first data. 
One distinct component is also explaining the extra variation 
related to the combination of treatment and treatment × time 
in the first data in variable 60. In this case, the second data 
does not contain a distinct component. The common and 
distinct scores for simulating the combination of treatment 
and treatment × time effects as well as the simulated load-
ings can be seen in Fig. 3.
Case B is simulated to illustrate the advantage of PE-
ASCA model in comparison to the ASCA model of single 
Fig. 3  Simulated data for the case B and the scores over different time points and loadings obtained ASCA and PE-ASCA model
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data analysis. As a result of the ASCA model, the vari-
ation of each data set is distributed based on the experi-
mental design of the data. Thus, the variation of the time 
factor is separated from the combined treatment and treat-
ment × time effect. Variable 20 is related to the time fac-
tor (not shown). As can be seen from the ASCA result of 
the first data (Fig. 3), both common and distinct effects 
are present in the first score of the mean values over time. 
It means that there is an increasing trend of treatment 
levels of infected and CON groups, while the level of 
the other two groups is decreasing over time. The corre-
sponding loading plot shows the contribution of both vari-
ables 40 and 60. In the ASCA results of the second data, 
only an increasing trend in levels of infected and CON 
over time is present. Permutation test on effect matrices 
showed that the observed effect for time and combination 
of treatment and treatment × time are significant in both 
data sets (p value = 0.001 for 1000 iterations). On the 
other hand, the results of the PE-ASCA model show the 
ability of the model to correctly distinguish the common 
and distinct variation of β + αβ effect. More importantly, 
investigation of the loading plots shows that the variables 
are correctly disentangled for the common and distinct 
variation and no significant value can be seen for variable 
60 in the common component.
3.2  Experimental example and data acquisition
The PE-ASCA model is also implemented on a real NMR 
metabolomics data set obtained from different brains tissues 
of piglets in an intervention study of experimental blood-
stream infection. The data was already presented in its origi-
nal paper (Alinaghi et al. 2019). Here, a sub-set of data is 
re-analyzed with the PE-ASCA model.
In the experimental data, twenty-two piglets (Danish 
landrace × Large White × Duroc) were delivered at 90% 
gestation from two sows (defined as litter 1 and litter 2), 
while each delivered piglet were randomly allocated to one 
of the following three treatment groups: (i) a control group 
receiving intra-arterial saline and total parenteral nutrition 
(CON + TPN, n = 7), (ii) an infected group receiving Staph-
ylococcus epidermidis (SE) inoculation and total parenteral 
nutrition (SE + TPN, n = 5) or (iii) a colostrum supplemen-
tation group receiving the SE inoculation and bovine colos-
trum and supplementary parenteral nutrition (SE + COL, 
n = 10). Therefore, each piglet is attributed to a specific 
level of litter and treatment. A schematic overview of the 
Fig. 4  PE-ASCA result of the experimental NMR-metabolomics 
data, a schematic overview of the balanced experimental design of 
the SE study, b common score and loading plots of hypothalamus 
and midbrain, c distinct score and loading plots of hypothalamus. 
CON + TPN (green circles) represents the control group, SE + TPN 
(red circles) represents the infected group by Staphylococcus epider-
midis and SE + COL (blue circles) represents the colostrum supple-
mentation group. The stars represent the mean value of each treat-
ment group. In the loading plots: Ace acetate, GABA γ-aminobutyric 
acid, GPC glycerophosphocholine, Cho choline, Cr creatine, Lac 
lactate, m-I myo-inositol, NAA N-acetylaspartate, PC phosphocholine 
(Color figure online)
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experimental design is depicted in Fig. 4a. The brain regions 
of hypothalamus and midbrain were analyzed by HR-MAS 
NMR spectroscopy. A Bruker Avance III 600 MHz NMR 
spectrometer (Bruker BioSpin Gmbh, Rheinstetten, Ger-
many) equipped with a 5-mm HR-MAS probe was used for 
recording the 1H NMR spectrum at 281 K with a spinning 
speed of 5000 Hz. Detailed descriptions of nutritional com-
positions of the intervention diets and NMR data acquisition 
are available elsewhere (Alinaghi et al. 2019; Brunse et al. 
2018; Shen et al. 2015). In order to have a balanced design 
in the data, four samples from SE + COL group and one 
sample from CON + TPN group were removed from the data 
sets. The samples were chosen to be removed if they were 
outliers, otherwise they were randomly selected. Moreover, 
one sample was reconstructed by adding the normally dis-
tributed noise to the mean response of the SE + TPN sam-
ples in the first litter. The final NMR data set of hypothala-
mus and midbrain had the size of 18 × 330 containing the 
three samples in every treatment group of each litter and 
were used for the integrative analysis with PE-ASCA model.
For pre-processing of the data prior to analysis, the data 
were referenced to the trimethylsilyl-[2,2,3,3-2H4]-1-propi-
onate (TSP) signal at 0.0 ppm and phase- and baseline-cor-
rected. The spectral data was aligned through the local shift-
ing of customized intervals by interval-correlation-shifting 
algorithm (icoshift) (Savorani et al. 2010). The data were 
normalized to the total sum area under the peak and subdi-
vided into 0.01 ppm bins. The pareto-scaled aliphatic part 
(1.3 – 4.5 ppm) of the data, excluding the spectral regions 
containing ethanol and propylene glycol resonances (Ali-
naghi et al. 2019), was used for analysis.
A permutation test showed that the observed common 
litter and treatment effect are significant (p value = 0.003 
for litter effect and p value = 0.04 for treatment effect with 
1000 iterations). The PE-ASCA results show that two com-
ponents can be disentangled for the common treatment effect 
(Fig. 4b). The score plot shows that the variation related to 
the separation of the SE + TPN and CON + TPN groups 
from the other group can be explained by the first common 
PC, while the separation of the CON + TPN group from 
the other two groups can be explained by the second com-
mon PC. Inspection of the loading plots, which contains 
the spectral data that can be translated into specific metabo-
lites, reveals that the metabolite lactate can similarly explain 
the separation of the SE + TPN group in data sets of both 
compartments, while lactate is increased in intensity in the 
SE + TPN group. On the other hand, the alternation of the 
choline-containing metabolites, which is displayed in the 
loading plots, is of importance while the metabolites glyc-
erophosphocholine (GPC) and phosphocholine (PC) show a 
higher level in CON + TPN group in midbrain compartment.
For the midbrain data, the distinct treatment effect is not 
significant. It shows that there is no further variation in the 
midbrain data to explain the treatment effect. However, the 
distinct treatment effect in the hypothalamus data shows a 
p value = 0.06. The distinct score plot, explaining the treat-
ment variation in hypothalamus, is shown in Fig. 4c. Only 
the first distinct score illustrates further variation explaining 
the separation of two groups of CON + TPN and SE + TPN 
from each other. This separation is explaining a higher 
level of choline in the infected group as well as some other 
metabolites such as γ-aminobutyric acid, N-acetylaspartate 
and acetate.
4  Discussion
Ignoring the experimental design information can hamper 
the interpretation of the results in PCA. Therefore, ASCA 
have been developed to implement the available informa-
tion about the experimental design for a better modeling and 
successively better understanding of the biological system. 
The same approach can also be considered for analysis of the 
fused data sets, which could be more complicated than anal-
ysis of a single data. Implementing the information about 
experimental design can lead to better understanding of the 
common and distinct phenomena in integrative analysis of 
multiple data sets.
The simulated data in case A illustrated the advantages 
of the proposed model in comparison with data fusion with-
out consideration of the experimental design. The results 
represent the capability of the PE-ASCA in correctly esti-
mating the all designed factors in this high signal to noise 
ratio scenario where SCA and PE-SCA could not recover 
some factors. Here, SCA and P-ESCA are investigated for 
the comparison; however, the benefit of PE-ASCA can be 
extended to other fusion methods such as JIVE and SLIDE 
which do not use the available experimental design informa-
tion. Moreover, analysis of the individual differences could 
also be informative as it can reveal the common and distinct 
variation which is not part of the experimental design of the 
data sets.
The need for data fusion methods and their advantages in 
providing a deeper understanding of the biological systems 
are vastly discussed in the literature (Smilde et al. 2017; 
Smilde et al. 2005b; Song et al. 2019).The benefit of an 
integrative analysis of multiple data sets with the similar 
underlying experimental design is presented here. As dem-
onstrated with the analysis of the simulated data in case B, 
the common and distinct sources of information obtained 
from the two (or multiple) sets can be affected by each of 
the design factors or even their interaction. By taking the 
design effect into consideration when analyzing fused data 
sets, complementary knowledge about the underlying experi-
mental variation in the biological system can be obtained.
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Furthermore, the analysis of real experimental data illus-
trated the usefulness of the proposed model. This was done 
on brain metabolome data from an intervention study with 
pigs, and the results indicate that lactate levels are higher in 
the hypothalamus and midbrain sections of the infected pig-
lets. This is consistent with the conversion of glucose to lac-
tate, which can often be observed during sepsis conditions 
as a result of the glycolytic shift under anaerobic conditions, 
and it was also observed in the analysis of cerebrospinal fluid 
and plasma samples from piglets in this study (Alinaghi et al. 
2019). However, a glucose signal could not be detected in 
the HR-MAS data of brain samples. Regarding the choline-
containing metabolites (Corbin and Zeisel 2012), the infected 
piglets exhibited a higher level of PC and GPC, which may 
be associated to the alternation of membrane choline phos-
pholipid metabolism, and possibly the severity of the cerebral 
damage. Choline is a metabolite present in the cell and mito-
chondrial membrane and is essential for development of the 
brain and lipid metabolism (Khovidhunkit et al. 2004).
5  Conclusions
In this study, an integrative analysis of multiple designed data 
sets is investigated by incorporating the experimental design 
information in a data fusion model. In this way, the proposed 
PE-ASCA model can reveal the common and distinct variation 
associated with various sources of experimental factors (such 
as time, treatment and litter) in the data sets. Therefore, this 
method can provide easier interpretation of induced metabo-
lite alternations in fusion of multiple data sets from different 
biological compartments or analytical platforms.
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